Global Oncology Targeted Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 112
Published Date: 06 Feb 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags
Description
Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
According to our (Global Info Research) latest study, the global Oncology Targeted Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Oncology Targeted Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncology Targeted Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oncology Targeted Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oncology Targeted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oncology Targeted Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Targeted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Targeted Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Eisai, Zelgen, Cipla and Natco Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oncology Targeted Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Market segment by Application
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Targeted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Targeted Therapy, with revenue, gross margin and global market share of Oncology Targeted Therapy from 2018 to 2023.
Chapter 3, the Oncology Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oncology Targeted Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Targeted Therapy.
Chapter 13, to describe Oncology Targeted Therapy research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oncology Targeted Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology Targeted Therapy by Type
1.3.1 Overview: Global Oncology Targeted Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oncology Targeted Therapy Consumption Value Market Share by Type in 2022
1.3.3 Sorafenib
1.3.4 Lenvatinib
1.3.5 Regorafenib
1.3.6 Osimertinib
1.3.7 Anlotinib
1.3.8 Alectinib
1.3.9 Other
1.4 Global Oncology Targeted Therapy Market by Application
1.4.1 Overview: Global Oncology Targeted Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Oncology Targeted Therapy Market Size & Forecast
1.6 Global Oncology Targeted Therapy Market Size and Forecast by Region
1.6.1 Global Oncology Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oncology Targeted Therapy Market Size by Region, (2018-2029)
1.6.3 North America Oncology Targeted Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Oncology Targeted Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oncology Targeted Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Oncology Targeted Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oncology Targeted Therapy Market Size and Prospect (2018-2029)
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Oncology Targeted Therapy Product and Solutions
2.1.4 Bayer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments and Future Plans
2.2 Eisai
2.2.1 Eisai Details
2.2.2 Eisai Major Business
2.2.3 Eisai Oncology Targeted Therapy Product and Solutions
2.2.4 Eisai Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eisai Recent Developments and Future Plans
2.3 Zelgen
2.3.1 Zelgen Details
2.3.2 Zelgen Major Business
2.3.3 Zelgen Oncology Targeted Therapy Product and Solutions
2.3.4 Zelgen Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zelgen Recent Developments and Future Plans
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Oncology Targeted Therapy Product and Solutions
2.4.4 Cipla Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cipla Recent Developments and Future Plans
2.5 Natco Pharma
2.5.1 Natco Pharma Details
2.5.2 Natco Pharma Major Business
2.5.3 Natco Pharma Oncology Targeted Therapy Product and Solutions
2.5.4 Natco Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Natco Pharma Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Oncology Targeted Therapy Product and Solutions
2.6.4 AstraZeneca Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Oncology Targeted Therapy Product and Solutions
2.7.4 Novartis Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Oncology Targeted Therapy Product and Solutions
2.8.4 Roche Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Recent Developments and Future Plans
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business
2.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Product and Solutions
2.9.4 Bristol-Myers Squibb Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Oncology Targeted Therapy Product and Solutions
2.10.4 Pfizer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 BEACON Pharma
2.11.1 BEACON Pharma Details
2.11.2 BEACON Pharma Major Business
2.11.3 BEACON Pharma Oncology Targeted Therapy Product and Solutions
2.11.4 BEACON Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BEACON Pharma Recent Developments and Future Plans
2.12 Jiangxi Shanxiang
2.12.1 Jiangxi Shanxiang Details
2.12.2 Jiangxi Shanxiang Major Business
2.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Product and Solutions
2.12.4 Jiangxi Shanxiang Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Jiangxi Shanxiang Recent Developments and Future Plans
2.13 Yao Pharma
2.13.1 Yao Pharma Details
2.13.2 Yao Pharma Major Business
2.13.3 Yao Pharma Oncology Targeted Therapy Product and Solutions
2.13.4 Yao Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Yao Pharma Recent Developments and Future Plans
2.14 CSPC
2.14.1 CSPC Details
2.14.2 CSPC Major Business
2.14.3 CSPC Oncology Targeted Therapy Product and Solutions
2.14.4 CSPC Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 CSPC Recent Developments and Future Plans
2.15 CHIATAI Tianqing
2.15.1 CHIATAI Tianqing Details
2.15.2 CHIATAI Tianqing Major Business
2.15.3 CHIATAI Tianqing Oncology Targeted Therapy Product and Solutions
2.15.4 CHIATAI Tianqing Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 CHIATAI Tianqing Recent Developments and Future Plans
2.16 Simcere
2.16.1 Simcere Details
2.16.2 Simcere Major Business
2.16.3 Simcere Oncology Targeted Therapy Product and Solutions
2.16.4 Simcere Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Simcere Recent Developments and Future Plans
3.1 Global Oncology Targeted Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oncology Targeted Therapy by Company Revenue
3.2.2 Top 3 Oncology Targeted Therapy Players Market Share in 2022
3.2.3 Top 6 Oncology Targeted Therapy Players Market Share in 2022
3.3 Oncology Targeted Therapy Market: Overall Company Footprint Analysis
3.3.1 Oncology Targeted Therapy Market: Region Footprint
3.3.2 Oncology Targeted Therapy Market: Company Product Type Footprint
3.3.3 Oncology Targeted Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Oncology Targeted Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oncology Targeted Therapy Market Forecast by Type (2024-2029)
5.1 Global Oncology Targeted Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Oncology Targeted Therapy Market Forecast by Application (2024-2029)
6.1 North America Oncology Targeted Therapy Consumption Value by Type (2018-2029)
6.2 North America Oncology Targeted Therapy Consumption Value by Application (2018-2029)
6.3 North America Oncology Targeted Therapy Market Size by Country
6.3.1 North America Oncology Targeted Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Oncology Targeted Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Oncology Targeted Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Oncology Targeted Therapy Market Size and Forecast (2018-2029)
7.1 Europe Oncology Targeted Therapy Consumption Value by Type (2018-2029)
7.2 Europe Oncology Targeted Therapy Consumption Value by Application (2018-2029)
7.3 Europe Oncology Targeted Therapy Market Size by Country
7.3.1 Europe Oncology Targeted Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Oncology Targeted Therapy Market Size and Forecast (2018-2029)
7.3.3 France Oncology Targeted Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oncology Targeted Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Oncology Targeted Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Oncology Targeted Therapy Market Size and Forecast (2018-2029)
8.1 Asia-Pacific Oncology Targeted Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oncology Targeted Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Oncology Targeted Therapy Market Size by Region
8.3.1 Asia-Pacific Oncology Targeted Therapy Consumption Value by Region (2018-2029)
8.3.2 China Oncology Targeted Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Oncology Targeted Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Oncology Targeted Therapy Market Size and Forecast (2018-2029)
8.3.5 India Oncology Targeted Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oncology Targeted Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Oncology Targeted Therapy Market Size and Forecast (2018-2029)
9.1 South America Oncology Targeted Therapy Consumption Value by Type (2018-2029)
9.2 South America Oncology Targeted Therapy Consumption Value by Application (2018-2029)
9.3 South America Oncology Targeted Therapy Market Size by Country
9.3.1 South America Oncology Targeted Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Oncology Targeted Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Oncology Targeted Therapy Market Size and Forecast (2018-2029)
10.1 Middle East & Africa Oncology Targeted Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oncology Targeted Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Oncology Targeted Therapy Market Size by Country
10.3.1 Middle East & Africa Oncology Targeted Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Oncology Targeted Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oncology Targeted Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Oncology Targeted Therapy Market Size and Forecast (2018-2029)
11.1 Oncology Targeted Therapy Market Drivers
11.2 Oncology Targeted Therapy Market Restraints
11.3 Oncology Targeted Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12.1 Oncology Targeted Therapy Industry Chain
12.2 Oncology Targeted Therapy Upstream Analysis
12.3 Oncology Targeted Therapy Midstream Analysis
12.4 Oncology Targeted Therapy Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oncology Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncology Targeted Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oncology Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oncology Targeted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Bayer Company Information, Head Office, and Major Competitors
Table 6. Bayer Major Business
Table 7. Bayer Oncology Targeted Therapy Product and Solutions
Table 8. Bayer Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Bayer Recent Developments and Future Plans
Table 10. Eisai Company Information, Head Office, and Major Competitors
Table 11. Eisai Major Business
Table 12. Eisai Oncology Targeted Therapy Product and Solutions
Table 13. Eisai Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Eisai Recent Developments and Future Plans
Table 15. Zelgen Company Information, Head Office, and Major Competitors
Table 16. Zelgen Major Business
Table 17. Zelgen Oncology Targeted Therapy Product and Solutions
Table 18. Zelgen Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Zelgen Recent Developments and Future Plans
Table 20. Cipla Company Information, Head Office, and Major Competitors
Table 21. Cipla Major Business
Table 22. Cipla Oncology Targeted Therapy Product and Solutions
Table 23. Cipla Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Cipla Recent Developments and Future Plans
Table 25. Natco Pharma Company Information, Head Office, and Major Competitors
Table 26. Natco Pharma Major Business
Table 27. Natco Pharma Oncology Targeted Therapy Product and Solutions
Table 28. Natco Pharma Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Natco Pharma Recent Developments and Future Plans
Table 30. AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Oncology Targeted Therapy Product and Solutions
Table 33. AstraZeneca Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. AstraZeneca Recent Developments and Future Plans
Table 35. Novartis Company Information, Head Office, and Major Competitors
Table 36. Novartis Major Business
Table 37. Novartis Oncology Targeted Therapy Product and Solutions
Table 38. Novartis Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Novartis Recent Developments and Future Plans
Table 40. Roche Company Information, Head Office, and Major Competitors
Table 41. Roche Major Business
Table 42. Roche Oncology Targeted Therapy Product and Solutions
Table 43. Roche Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Roche Recent Developments and Future Plans
Table 45. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 46. Bristol-Myers Squibb Major Business
Table 47. Bristol-Myers Squibb Oncology Targeted Therapy Product and Solutions
Table 48. Bristol-Myers Squibb Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bristol-Myers Squibb Recent Developments and Future Plans
Table 50. Pfizer Company Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Oncology Targeted Therapy Product and Solutions
Table 53. Pfizer Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer Recent Developments and Future Plans
Table 55. BEACON Pharma Company Information, Head Office, and Major Competitors
Table 56. BEACON Pharma Major Business
Table 57. BEACON Pharma Oncology Targeted Therapy Product and Solutions
Table 58. BEACON Pharma Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BEACON Pharma Recent Developments and Future Plans
Table 60. Jiangxi Shanxiang Company Information, Head Office, and Major Competitors
Table 61. Jiangxi Shanxiang Major Business
Table 62. Jiangxi Shanxiang Oncology Targeted Therapy Product and Solutions
Table 63. Jiangxi Shanxiang Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Jiangxi Shanxiang Recent Developments and Future Plans
Table 65. Yao Pharma Company Information, Head Office, and Major Competitors
Table 66. Yao Pharma Major Business
Table 67. Yao Pharma Oncology Targeted Therapy Product and Solutions
Table 68. Yao Pharma Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Yao Pharma Recent Developments and Future Plans
Table 70. CSPC Company Information, Head Office, and Major Competitors
Table 71. CSPC Major Business
Table 72. CSPC Oncology Targeted Therapy Product and Solutions
Table 73. CSPC Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. CSPC Recent Developments and Future Plans
Table 75. CHIATAI Tianqing Company Information, Head Office, and Major Competitors
Table 76. CHIATAI Tianqing Major Business
Table 77. CHIATAI Tianqing Oncology Targeted Therapy Product and Solutions
Table 78. CHIATAI Tianqing Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. CHIATAI Tianqing Recent Developments and Future Plans
Table 80. Simcere Company Information, Head Office, and Major Competitors
Table 81. Simcere Major Business
Table 82. Simcere Oncology Targeted Therapy Product and Solutions
Table 83. Simcere Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Simcere Recent Developments and Future Plans
Table 85. Global Oncology Targeted Therapy Revenue (USD Million) by Players (2018-2023)
Table 86. Global Oncology Targeted Therapy Revenue Share by Players (2018-2023)
Table 87. Breakdown of Oncology Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Oncology Targeted Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Oncology Targeted Therapy Players
Table 90. Oncology Targeted Therapy Market: Company Product Type Footprint
Table 91. Oncology Targeted Therapy Market: Company Product Application Footprint
Table 92. Oncology Targeted Therapy New Market Entrants and Barriers to Market Entry
Table 93. Oncology Targeted Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Oncology Targeted Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Oncology Targeted Therapy Consumption Value Share by Type (2018-2023)
Table 96. Global Oncology Targeted Therapy Consumption Value Forecast by Type (2024-2029)
Table 97. Global Oncology Targeted Therapy Consumption Value by Application (2018-2023)
Table 98. Global Oncology Targeted Therapy Consumption Value Forecast by Application (2024-2029)
Table 99. North America Oncology Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Oncology Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Oncology Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Oncology Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Oncology Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Oncology Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Oncology Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Oncology Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Oncology Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Oncology Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Oncology Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Oncology Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Oncology Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Oncology Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Oncology Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Oncology Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Oncology Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Oncology Targeted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Oncology Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Oncology Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Oncology Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Oncology Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Oncology Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Oncology Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Oncology Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Oncology Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Oncology Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Oncology Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Oncology Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Oncology Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Oncology Targeted Therapy Raw Material
Table 130. Key Suppliers of Oncology Targeted Therapy Raw Materials
List of Figures
Figure 1. Oncology Targeted Therapy Picture
Figure 2. Global Oncology Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncology Targeted Therapy Consumption Value Market Share by Type in 2022
Figure 4. Sorafenib
Figure 5. Lenvatinib
Figure 6. Regorafenib
Figure 7. Osimertinib
Figure 8. Anlotinib
Figure 9. Alectinib
Figure 10. Other
Figure 11. Global Oncology Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 12. Oncology Targeted Therapy Consumption Value Market Share by Application in 2022
Figure 13. Hospital Picture
Figure 14. Retail Pharmacy Picture
Figure 15. Other Picture
Figure 16. Global Oncology Targeted Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Oncology Targeted Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Oncology Targeted Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Oncology Targeted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Oncology Targeted Therapy Consumption Value Market Share by Region in 2022
Figure 21. North America Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Oncology Targeted Therapy Revenue Share by Players in 2022
Figure 27. Oncology Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Oncology Targeted Therapy Market Share in 2022
Figure 29. Global Top 6 Players Oncology Targeted Therapy Market Share in 2022
Figure 30. Global Oncology Targeted Therapy Consumption Value Share by Type (2018-2023)
Figure 31. Global Oncology Targeted Therapy Market Share Forecast by Type (2024-2029)
Figure 32. Global Oncology Targeted Therapy Consumption Value Share by Application (2018-2023)
Figure 33. Global Oncology Targeted Therapy Market Share Forecast by Application (2024-2029)
Figure 34. North America Oncology Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Oncology Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Oncology Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Oncology Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Oncology Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Oncology Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. France Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Oncology Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Oncology Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Oncology Targeted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 51. China Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 54. India Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Oncology Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Oncology Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Oncology Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Oncology Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Oncology Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Oncology Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Oncology Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 68. Oncology Targeted Therapy Market Drivers
Figure 69. Oncology Targeted Therapy Market Restraints
Figure 70. Oncology Targeted Therapy Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Oncology Targeted Therapy in 2022
Figure 73. Manufacturing Process Analysis of Oncology Targeted Therapy
Figure 74. Oncology Targeted Therapy Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Related Reports
03 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
